Work

MCL-1 Up-Regulation through MAPK Activation Confers Acquired Resistance to BCL-2 Inhibitor ABT-199 in Pre-Clinical AML Models

Year: 2017

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2017.09.025

Authors: Qi Zhang, Lina Han, Rongqing Pan, Ce Shi, Ryan Jeremy, Man Chun John Ma, Steven Kurtz, Hong Mu, Vivian R. Ruvolo, Helen Ma, Yingchang Mi, Jeffrey Tyner, Letai Anthony, Richard Eric Davis, Michael Andreeff, Marina Konopleva

Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Oregon Health & Science University, Chinese Academy of Medical Sciences & Peking Union Medical College

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2761324684

FWCI:

Cites:

Cited by: 1

Related to: 10